{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:29:51Z","timestamp":1792074591608,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.pharma.2024.04.004","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T05:55:21Z","timestamp":1713765321000},"page":"822-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["[18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET imaging repurposed for quantitative estimation of blood-brain barrier permeability in a rat model of Alzheimer's disease"],"prefix":"10.1016","volume":"82","author":[{"given":"Am\u00e9lie","family":"Soyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Goutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Leterrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol\u00e8ne","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Larrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Selingue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Winkeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Sarazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bottlaender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.04.004_bib0005","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.3390\/ijms23094962","article-title":"Biomarkers for Alzheimer's disease in the current state: a narrative review","volume":"23","author":"Gunes","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0010","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer Dementia"},{"key":"10.1016\/j.pharma.2024.04.004_bib0015","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/alz.12422","article-title":"Using the Alzheimer's disease neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease","volume":"18","author":"Veitch","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharma.2024.04.004_bib0020","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1093\/brain\/awad135","article-title":"Age-related and amyloid-beta-independent tau deposition and its downstream effects","volume":"146","author":"Wuestefeld","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2024.04.004_bib0025","doi-asserted-by":"crossref","first-page":"624330","DOI":"10.3389\/fnagi.2021.624330","article-title":"PET neuroimaging of Alzheimer's disease: radiotracers and their utility in clinical research","volume":"13","author":"Bao","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awy079","article-title":"Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease","volume":"141","author":"Hamelin","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.pharma.2024.04.004_bib0035","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41467-023-36377-4","article-title":"Radiochemistry for positron emission tomography","volume":"14","author":"Rong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharma.2024.04.004_bib0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharma.2024.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.pharma.2024.04.004_bib0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharma.2024.04.004_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharma.2024.04.004_bib0060","first-page":"9","article-title":"Markers for blood-brain barrier integrity: how appropriate is Evans blue in the twenty-first century and what are the alternatives?","author":"Saunders","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharma.2024.04.004_bib0070","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1038\/s41596-021-00613-2","article-title":"Kit-based synthesis of 2-deoxy-2-[18F]-fluoro-D-sorbitol for bacterial imaging","volume":"16","author":"Mota","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.pharma.2024.04.004_bib0075","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/pharmaceutics13111752","article-title":"[18F]2-Fluoro-2-deoxy-sorbitol PET imaging for quantitative monitoring of enhanced blood-brain barrier permeability induced by focused ultrasound","volume":"13","author":"Hugon","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.04.004_bib0080","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1523\/JNEUROSCI.3672-12.2013","article-title":"A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric a\u03b2, and frank neuronal loss","volume":"33","author":"Cohen","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11307-007-0125-0","article-title":"The synthesis of 18F-FDS and its potential application in molecular imaging","volume":"10","author":"Li","year":"2008","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pharma.2024.04.004_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/RLI.0000000000000723","article-title":"A comprehensive view on MRI techniques for imaging blood-brain barrier integrity","volume":"56","author":"Elschot","year":"2021","journal-title":"Invest Radiol"},{"key":"10.1016\/j.pharma.2024.04.004_bib0095","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuroscience.2020.10.015","article-title":"Challenges and perspectives of the hybridization of PET with functional MRI or ultrasound for neuroimaging","volume":"474","author":"Tournier","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2024.04.004_bib0100","first-page":"1123","article-title":"Evaluation of 1-deoxy-1-[18F]fluoro-D-mannitol as a brain imaging tracer for measuring osmotic disruption following cancer therapy","volume":"55","author":"Elmaleh","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharma.2024.04.004_bib0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/RLU.0000000000002494","article-title":"Novel functional renal PET imaging with 18F-FDS in human subjects","volume":"44","author":"Werner","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.pharma.2024.04.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X241236755","article-title":"Imaging quantitative changes in blood-brain barrier permeability using [18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET in relation to glial cell recruitment in a mouse model of endotoxemia","author":"Leterrier","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharma.2024.04.004_bib0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharma.2024.04.004_bib0120","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood-brain barrier dysfunction in Alzheimer's disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0125","doi-asserted-by":"crossref","first-page":"1258640","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0130","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.7150\/thno.56059","article-title":"Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study","volume":"11","author":"Chaney","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pharma.2024.04.004_bib0135","doi-asserted-by":"crossref","first-page":"259ra146","DOI":"10.1126\/scitranslmed.3009815","article-title":"Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography","volume":"6","author":"Weinstein","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharma.2024.04.004_bib0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","article-title":"Magnetic resonance imaging of blood-brain barrier permeability in dementia","volume":"474","author":"Chagnot","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharma.2024.04.004_bib0145","doi-asserted-by":"crossref","first-page":"1111448","DOI":"10.3389\/fnagi.2023.1111448","article-title":"Contributions of blood-brain barrier imaging to neurovascular unit pathophysiology of Alzheimer's disease and related dementias","volume":"15","author":"Uchida","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0150","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1177\/0271678X231180035","article-title":"Blood-brain barrier breakdown is linked to tau pathology and neuronal injury in a differential manner according to amyloid deposition","volume":"43","author":"Moon","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharma.2024.04.004_bib0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1144036","article-title":"Imaging blood\u2013brain barrier disruption in neuroinflammation and Alzheimer's disease","volume":"15","author":"Lee","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.pharma.2024.04.004_bib0160","first-page":"152244","article-title":"Blood-brain barrier leakage in patients with early Alzheimer disease","volume":"31","author":"Haar","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.pharma.2024.04.004_bib0165","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:33:45Z","timestamp":1724963625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0003450924000610"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[18F]2-fluoro-2-deoxy-sorbitol ([18F]FDS) PET imaging repurposed for quantitative estimation of blood-brain barrier permeability in a rat model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS on behalf of Acad\u00e9mie Nationale de Pharmacie.","name":"copyright","label":"Copyright"}]}}